BRAIDWELL LP

Key Holdings

The portfolio is dominated by mid-to-large cap healthcare companies, with a heavy weighting in specific therapeutic areas.

• Top Position: The largest holding is Guardant Health Inc (GH), comprising 14.02% of the portfolio ($286.28M). This represents a massive, concentrated bet on liquid biopsy and oncology diagnostics.
• Significant Stakes: Novocure Ltd is the second-largest holding at 10.29% ($210.04M). Braidwell significantly increased this position by 50.1% during the quarter, adding $72.19M, signaling strong conviction in their tumor treating fields platform.
• Core Holdings: Xenon Pharmaceuticals (XENE) and Neurocrine Biosciences (NBIX) round out the top four, making up 7.09% and 6.05% of the portfolio, respectively. These positions suggest a focus on neuroscience and central nervous system disorders.
• Notable Weight: Repligen Corp holds a 4.99% weight, indicating exposure to the bioprocessing/enabling technology side of the healthcare ecosystem.